Elevation Point Wealth Partners LLC Acquires New Position in HCA Healthcare, Inc. $HCA

Elevation Point Wealth Partners LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 21,700 shares of the company’s stock, valued at approximately $8,461,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. Nomura Asset Management Co. Ltd. boosted its stake in HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Advisors Capital Management LLC boosted its holdings in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after acquiring an additional 2,604 shares during the period. Liberty Wealth Management LLC acquired a new stake in HCA Healthcare during the 4th quarter worth $1,905,000. Arrowstreet Capital Limited Partnership boosted its stake in shares of HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the period. Finally, Sunbelt Securities Inc. raised its stake in HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after acquiring an additional 3,945 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 5.6%

Shares of HCA stock opened at $429.08 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm’s 50 day moving average price is $397.16 and its two-hundred day moving average price is $444.14. The stock has a market cap of $92.90 billion, a price-to-earnings ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm earned $6.84 earnings per share. On average, equities analysts forecast that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is 10.45%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Barclays lowered their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research report on Monday, July 27th. Cantor Fitzgerald decreased their price objective on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. UBS Group cut their price target on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Oppenheimer reduced their target price on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. Finally, The Goldman Sachs Group decreased their price target on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research note on Tuesday, July 28th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.